DRAPER, Utah, Oct. 15, 2024 (GLOBE NEWSWIRE) -- HealthEquity, Inc. (Nasdaq: HQY) ("HealthEquity") in celebration of National HSA Awareness Day, has launched HSAnswers. Powered by a comprehensive and bespoke database of resources, research, and insights, the free-to-use AI chat tool can help individuals obtain clear answers to questions about HSAs and other consumer-directed benefits.
In 2024 HealthEquity surveyed over 600 employees who said their top benefits challenge was being overwhelmed by the amount of information available to them. HSAnswers helps provide the extra support employees are asking for by serving up the answer for them without them having to dig through a mountain of information. HSAnswers offers instant, educational information about HSAs and other benefits.
“Understanding benefits can be complicated especially if you don’t know where to go to get answers or are intimidated to get help,” said Tene Raymond, director of consumer engagement at HealthEquity. “As open enrollment season gets underway, and employees evaluate their plans and benefit options, HSAnswers can be your personal benefits assistant—meaning that it can help educate and provide clarity around consumer-directed benefit (CDB) topics so you can make better decisions about what’s best for you and your family.”
The AI-powered tool does not generate responses outside of the data HealthEquity provides. HSAnswers focuses on content that helps visitors learn about a full range of CDB benefit products and resources including HSAs, FSAs, HRAs, and beyond. HSAnswers provides benefits answers people want when they need it.
Visitors can find and use HSAnswers on the HealthEquity.com home page on the top navigation menu. Key features of HSAnswers include:
"With HSAnswers, we aim to help bridge the benefits knowledge gap and empower more Americans to take full control of their health and savings," said Raymond. "This tool represents our commitment to simplify benefit education and make healthcare benefits more accessible and manageable for everyone.”
About HealthEquity
HealthEquity and its subsidiaries administer HSAs and various other consumer-directed benefits for over 16 million accounts, working in close partnership with employers, benefits advisors, and health and retirement plan providers who share our unwavering commitment to our mission of saving and improving lives by empowering healthcare consumers. Through cutting-edge solutions, innovation, and a relentless focus on improving health outcomes, we empower individuals to take control of their healthcare journey while ultimately enhancing their overall well-being. Learn more about our “Purple service” and approach at www.healthequity.com.
Media Contact:
Amy Cerny
Director of Corporate Communications
This email address is being protected from spambots. You need JavaScript enabled to view it.
Check out the HealthEquity newsroom for the latest HealthEquity news, original research, fresh content, and social media highlights.
Last Trade: | US$84.52 |
Daily Change: | 2.03 2.46 |
Daily Volume: | 934,108 |
Market Cap: | US$7.320B |
March 18, 2025 February 18, 2025 January 13, 2025 November 12, 2024 |
Cue Biopharma is developing the first-ever class of therapeutics for the treatment of cancer that mimic the natural signals, or “Cues”, of the immune system. This novel class of injectable biologics selectively engages and modulates tumor-specific T cells directly within the patient’s body to transform...
CLICK TO LEARN MOREImmix Biopharma is a clinical-stage biopharmaceutical company pioneering a novel class of CAR-T cell therapies and Tissue-Specific Therapeutics targeting oncology and immuno-dysregulated diseases with >75 patients treated to-date. Our lead cell therapy asset is NXC-201...
CLICK TO LEARN MOREEnd of content
No more pages to load